Abstract
For the past 15-20 years, the intracellular delivery and silencing activity of oligodeoxynucleotides have been essentially completely dependent on the use of a delivery technology (e.g. lipofection). We have developed a method (called 'gymnosis') that does not require the use of any transfection reagent or any additives to serum whatsoever, but rather takes advantage of the normal growth properties of cells in tissue culture in order to promote productive oligonucleotide uptake. This robust method permits the sequence-specific silencing of multiple targets in a large number of cell types in tissue culture, both at the protein and mRNA level, at concentrations in the low micromolar range. Optimum results were obtained with locked nucleic acid (LNA) phosphorothioate gap-mers. By appropriate manipulation of oligonucleotide dosing, this silencing can be continuously maintained with little or no toxicity for >240 days. High levels of oligonucleotide in the cell nucleus are not a requirement for gene silencing, contrary to long accepted dogma. In addition, gymnotic delivery can efficiently deliver oligonucleotides to suspension cells that are known to be very difficult to transfect. Finally, the pattern of gene silencing of in vitro gymnotically delivered oligonucleotides correlates particularly well with in vivo silencing. The establishment of this link is of particular significance to those in the academic research and drug discovery and development communities.
MeSH Terms
Animals
Cell Line, Tumor
Gene Silencing
Humans
Indicators and Reagents
Mice
Oligonucleotides/administration & dosage,analysis
Oligonucleotides, Antisense/administration & dosage,analysis
Proto-Oncogene Proteins c-bcl-2/genetics,metabolism
Transfection
Chemicals
Indicators and Reagents
Oligonucleotides
Oligonucleotides, Antisense
Proto-Oncogene Proteins c-bcl-2
locked nucleic acid
Authors & Affiliations
15 authors, click to expand affiliations / ORCID
Stein C A
Albert Einstein-Montefiore Cancer Center, Montefiore Medical Center, Bronx, NY 10467, USA. cstein@montefiore.org
Hansen J Bo
Lai Johnathan
Wu SiJian
Voskresenskiy Anatoliy
Høg Anja
Worm Jesper
Hedtjärn Maj
Souleimanian Naira
Miller Paul
Soifer Harris S
Castanotto Daniella
Benimetskaya Luba
Ørum Henrik
Koch Troels
References (14)
14 references, click to expand
-
Role of RNase H in hybrid-arrested translation by antisense oligonucleotides.
Proc Natl Acad Sci U S A. 1988 Jul;85(14):5011-5
PMID: 2839827
-
Disruption of GW bodies impairs mammalian RNA interference.
Nat Cell Biol. 2005 Dec;7(12):1267-74
PMID: 16284622
-
Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity.
Adv Drug Deliv Rev. 2007 Mar 30;59(2-3):164-82
PMID: 17481774
-
Characterization of antisense oligonucleotides comprising 2'-deoxy-2'-fluoro-beta-D-arabinonucleic acid (FANA): specificity, potency, and duration of activity.
Ann N Y Acad Sci. 2006 Oct;1082:91-102
PMID: 17145930
-
Argonaute 2/RISC resides in sites of mammalian mRNA decay known as cytoplasmic bodies.
Nat Cell Biol. 2005 Jun;7(6):633-6
PMID: 15908945
-
Phosphorothioate oligodeoxyribonucleotides dissociate from cationic lipids before entering the nucleus.
Nucleic Acids Res. 1998 Apr 15;26(8):2016-23
PMID: 9518498
-
Relative Bcl-2 independence of drug-induced cytotoxicity and resistance in 518A2 melanoma cells.
Clin Cancer Res. 2004 Dec 15;10(24):8371-9
PMID: 15623615
-
G3139, an anti-Bcl-2 antisense oligomer that binds heparin-binding growth factors and collagen I, alters in vitro endothelial cell growth and tubular morphogenesis.
Clin Cancer Res. 2009 Apr 15;15(8):2797-807
PMID: 19351753
-
Phosphorothioate oligodeoxynucleotides and G3139 induce apoptosis in 518A2 melanoma cells.
Mol Cancer Ther. 2005 Feb;4(2):305-15
PMID: 15713901
-
Intracellular disposition and metabolism of fluorescently-labeled unmodified and modified oligonucleotides microinjected into mammalian cells.
Nucleic Acids Res. 1993 Aug 11;21(16):3857-65
PMID: 8396239
-
Telomerase targeted oligonucleotide thio-phosphoramidates in T24-luc bladder cancer cells.
J Cell Biochem. 2008 May 15;104(2):444-52
PMID: 18044713
-
Site and mechanism of antisense inhibition by C-5 propyne oligonucleotides.
Biochemistry. 1995 Apr 18;34(15):5044-53
PMID: 7536034
-
Interactions of antisense DNA oligonucleotide analogs with phospholipid membranes (liposomes).
Nucleic Acids Res. 1991 Oct 25;19(20):5551-9
PMID: 1945832
-
Toxicogenomics of non-viral vectors for gene therapy: a microarray study of lipofectin- and oligofectamine-induced gene expression changes in human epithelial cells.
J Drug Target. 2003 Jul;11(6):311-23
PMID: 14668052